Member Info for Indiscipline

Cheers cloudy we all need a laugh.

The definitive term is

No Direct(or) Action. You can all fill in what this applies to.

NDA's = No Director assistance. Sorted.

You can use assistance for any category you wish, such as with shareholder communication.

Actually as said before the results are all that matters. They can't say anything only what they do holds any water.
As others have said the board are getting a bloody stiff talking to from institutions.

NDA = Need delivery acutely...

Shakin from what I took away they were capitalised fine and were not going to be hitting us for cash. The fact is that on any success the stock will rise quickly.

They will be damn careful on any raise as they know done poorly this kills the stock price. When it is done effectively it adds to the price as the institutions and the general market know they have the product and funds to exploit their product.

The fear is not on a raise as many AIM companies have proven. The fear is that the science don't work. Everything hangs on results.

If it works we partner up with huge pharma which is what SK and GC have stated numerous times and collect the cash...

Looking at the morningstar some insti's have been selling to lock in gains and bonuses. There are others accumulating.
This will go through to the end of the year as books get balanced.

What we may see are sharp movements as liquidity contracts and insti's come in for the year ahead which is looking very good with contract and revs. We should be around 40-50 mil by June.

Shares consolidate and breakout or breakdown. We are in consolidation phase but the revs kicking in should get us out after January not even taking into account wearables and Imutex. Personally, I like some free shares kicking our way rather than selling cheap.

With the stimulation in antibodies which can be over stimulated by the vaccine if the foralumab results are good this can be combined in a whole group of the vaccines to provide safer results for the vulnerable and there is a huge cohort of elderly and vulnerable who fall within this demographic.

We don't have to worry about the vaccines, their success can very well mean our success. There are ever growing numbers of long covid patients that would benefit hugely from this drug alone. It is almost impossible to overestimate the effects of positive results here for whole swathes of the population from cancer sufferers to all.

It is frankly why they are taking a laissez faire approach with PR and communication. The results are their only concern and ours. So far it has been positive we all need that to continue. The science here rules everything. With success they partner up with a huge pharma (who do the heavy lifting) and we all collect the cash...

The pipeline is everything in the next three months we have this and the MS trials.

There are so many other areas that their pharma covers it gives us shot after shot.

This could go against us. But this could go for us in an absolutely spectacular way.

You have to have the shareholding you can stomach, because, before February the market will most likely work us hard.
By February the market can work hard for us...

If you have auto immune diseases you need to know that a surge in antibodies is not going to have the effect of those antibodies attacking your system. Cytokine storm is very relevant news.

I hope they really have checked this area as well as all the others out thoroughly... Vax is great but special groups need to feel safe.

The approvals are needed. Timetable on that has to be discussed. There has been top slicing.

If CF comes out repeatedly and does not have news his power gets diluted. So right now until we get some news or approval it is a bit tricky for him.

LT we are fine and approval should be soon. We just need to get over the hump.

Its weakening on vaccine news. Today may be one to just get through.

We need some HC approval news or contract news. Conversely if you are looking at wearables and Imutex we may be in top up period. If CF goes on Proactive we need to hear when approval is likely...

The fact there are more studies coming on board and new facilities being organised tells you revenue wise we aremoving forward just have to get through this period as we are thought to be hurt by this, when actually for secong generation vaccine it helps us.

He wants the share price rising steadily does not want volatility as it spooks the institutions. Steady riser means more instis can drop cash in and don't have to buy in and sell out in clumps. Long term its good for us as we become a safe place to park cash. As a finance guy he knows his angles.

BM03 if you have auto immune problems that is the key thing with the vaccine. What can it set off as it stimulates your system?
My mother is very concerned on that score and so am I.

The technology we are trialling has the potential to be an absolute game changer in this auto-immune area. This could be an addition for people with auto-immune difficulties when taking the vaccine.

Like you I am gonna top up when I can. The tech is everything, we just have to take an affordable amount of risk. Accustem has derisked matters to a significant degree and we have other shots as said before.

You have literally millions of people who are suffering from long Covid and who need their immune systems re-charged.
Also for people with auto-immune systems we have to be careful of how the vaccine responds to us.

lbc. Great work in getting some feedback from the Dr. You are right we need all areas to function.

The key element though is that the science works. If that doesn't nothing here functions. We'll get the answers for that shortly. If the science works, as it has in accustem, then partners will enter who have the heavyweight business acumen behind them to power the business on. Right now we have to wait for those results.

The actual trading volume is minute. Could fall below 80p. Support zones then are 72p and 66p.
At this point this stock is being given away.

GC's buy zone around 80 should give support for a little while. I think there would be huge pressure on management to get out and about from the institutions. Right now they are allowed to just concentrate on science.

There will be weekly contact from the guys that bought at £2 at the very minimum. When they speak GC listens.
They have not gone crazy so that is encouraging. GC buying is also a strong sign. We are in grin and bear it mode.

If December trials come in good it derisks the entire portfoilio. Then MS trials in Jan which we can look forward to with more relish. This is a risky play as the MM's can move it around on the light volume. I understand others being angry, I'm just psychotic...

The guy writes 100 posts on one single stock. Has nothing to say. Probably paid troll. They get paid on how many posts they generate. His cr*p is blocking the board which is what it's designed to do. This is so others who have real info have their posts diluted.

Filter him and then you can digest what people with info have to say.

End of Jan I would say nice we'll be into 30's and then Feb more great stuff to follow.

The only one who seems to get a reply from her emails is BM03 are you getting anything now? Though not sure anything helps.

It's just grin and bear it. We got on the rollercoaster, we have to see the ride through, is the message that is being sent.

What I did like was GC went and purchased. That says something.

A bloody impressive addition. Strong board = strong company and a rising share price.
They highlighted again the expected rapid growth in the next phase.

Code for sit tight and watch this progress. This is a multi year compounder especially with new challenge models coming on tap in the next few months. They are not developed without buyers unlike the old regime and we got expanding facilities to add revenue. Another piece falls into place.

Filtered him as well. Anyone who does 100 posts and above on a single board is a mentally disturbed individual.
He has nothing meaningful to say.

This is a biotech stock we all know either it succeeds and rerates massively or it doesn't. This stock has 5 potential opportunities to re-rate with the most cutting edge Mab's technology out there and the Brazil trials derisk the portfolio as well as accustem shares. That is all that matters.

You gave detail nothing.

You came on here basically stating he's lying on wearables and just pulling numbers out for people he's speaking to. If you choose to impugn his reputation without evidence you get treated as a punk. Ok Bud.

Timescales have not got vaguer all around the same period. When you run a business that you build from a few million to over a hundred then start talking from experience. until then it's best you don't denigrate a reputation. Deals worth tens of millions take time; he's delivered and will deliver more. You just blah,blah blah.

Bud if you don't like what CF is doing sell up. Plenty of people will take your place. Cf has made deal after deal. Trust me this company can thrive without your money.